Skip to main content
SpringerLink
Log in

From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

In recent years a paradigm shift towards a patient-focused rather than a disease-focused approach occurred in many health care systems. The pharmacy profession experienced an accordant development. The traditional drug-oriented services expanded towards patient-oriented services. In oncology, pharmacists established central services for compounding of cytotoxic drugs and offered therapeutic drug monitoring for critical substances. Pharmaceutical care concepts are now being introduced to optimize individual drug therapy. Pharmaceutical care aims at improving safety and therapeutic outcomes and consequently, the patient’s quality of life. These objectives imply a close relationship to supportive care. To achieve this, a multidisciplinary approach seems to be beneficial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    PubMed  Google Scholar 

  2. Alliance for Aging Research (1998) When Medication Hurts Instead of Helps: Preventing Medication Problems in Older People. Washington D.C.

    Google Scholar 

  3. American Federation of Clinical Oncologic Societies (1998) Access to quality cancer care: consensus statement. J Clin Oncol 16:1628–1630

    PubMed  Google Scholar 

  4. American Society of Health-System Pharmacists (1996) ASHP guidelines on a standardized method for pharmaceutical care. Am J Health Syst Pharm 53:1713–1716

    PubMed  Google Scholar 

  5. Berard CM, Mahoney CD (1995). Cost-reducing treatment algorithms for antineoplastic drug-induced nausea and vomiting. Am J Health Syst Pharm 52:1879–1885

    CAS  Google Scholar 

  6. Broadfield L (1995) Pharmaceutical care in oncology pharmacy practice: A method for using outcome indicators. J Oncol Pharm Pract 1:9–14

    Google Scholar 

  7. Cipolle RJ, Strand LM, Morley PC (1998) Pharmaceutical Care Practice. McGraw-Hill, New York Chapter 3:73–120

  8. Dranitsaris G, Leung P, Warr D (2001) Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study. Support Care Cancer 9:611–618

    Article  CAS  PubMed  Google Scholar 

  9. Engstrom C, Hernandez I, Haywood J, Lilenbaum R (1999) The efficacy and cost effectiveness of new antiemetic guidelines. Oncol Nurs Forum 26:1453–1458

    CAS  PubMed  Google Scholar 

  10. Freidank A (1999) Schemata zur Prophylaxe von Zytostatika-induzierter Emesis und Nausea. Krankenhauspharmazie 20:49–54

    Google Scholar 

  11. Hepler CD (1997) Pharmaceutical Care and Therapeutic Outcomes Monitoring. J Appl Therap 1:285–294

    Google Scholar 

  12. Hepler CD, Strand LM (1990). Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47:533–543

    CAS  PubMed  Google Scholar 

  13. Hoare D, Beer C (1995) Guidelines for the pharmaceutical care of cancer patients. Pharm J 255:841–842

    Google Scholar 

  14. Hon YY, Evans WE (1998) Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach. Clin Chem 44:388–400

    CAS  PubMed  Google Scholar 

  15. Inhaltskatalog Onkologische Pharmazie (2000). http://www.ifahs.org/apotheker/inhaltskatalog.html

  16. Kennie NR, Schuster BG, Einarson TR (1998) Critical Analysis of the Pharmaceutical Care Research Literature. Ann Pharmacother 32:17–26

    CAS  Google Scholar 

  17. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of Adverse Drug Reactions in Hospitalized Patients. JAMA 279:1200–1205

    CAS  PubMed  Google Scholar 

  18. Liekweg A, Eckhardt M, Taylor SCM, Erdfelder E, Jaehde U (2003). Patient satisfaction with information on cancer treatment – A useful outcome measure for pharmaceutical care? Pharm World Sci, submitted for publication

  19. Lindley CM (1994). Pharmaceutical Care: The Chemotherapy Patient. US Pharmacist 56–78.

    Google Scholar 

  20. Mobach MP (2001) From the laboratory to pharmaceutical care research—Part I. Pharm World Sci 23:205–209

    Article  CAS  PubMed  Google Scholar 

  21. Quality Standards for the Oncology Pharmacy Service (2001) 3rd ed. Onkopress, Oldenburg, Germany

  22. Todd WE, Eichert JH, Toscani MR (1997) Disease Management—Building a Solid Foundation. Dis Manage Health Outcomes 1:26–31

    Google Scholar 

  23. Working Party Report (1997) Pharmaceutical care of cancer patients in the community. Pharm J 258:54–58

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacy, Department of Clinical Pharmacy, Rheinische Friedrich-Wilhelms-Universität Bonn, An der Immenburg 4, 53121, Bonn, Germany

    Andrea Liekweg, Martina Westfeld & Ulrich Jaehde

Authors
  1. Andrea Liekweg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martina Westfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulrich Jaehde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Jaehde.

Additional information

Presented as an invited lecture at the 15th International Symposium Supportive Care in Cancer, Berlin, Germany, June 18–21, 2003

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liekweg, A., Westfeld, M. & Jaehde, U. From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer 12, 73–79 (2004). https://doi.org/10.1007/s00520-003-0539-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-003-0539-4

Keywords

Search

Navigation